90 related articles for article (PubMed ID: 3038302)
1. Activation of human monocyte tumoricidal activity by C-reactive protein.
Barna BP; James K; Deodhar SD
Cancer Res; 1987 Aug; 47(15):3959-63. PubMed ID: 3038302
[TBL] [Abstract][Full Text] [Related]
2. Modulation of human monocyte chemotaxis and procoagulant activity by human C-reactive protein (CRP).
Whisler RL; Proctor VK; Downs EC; Mortensen RF
Lymphokine Res; 1986; 5(3):223-8. PubMed ID: 3747603
[TBL] [Abstract][Full Text] [Related]
3. Macrophage tumoricidal activity induced by human C-reactive protein.
Zahedi K; Mortensen RF
Cancer Res; 1986 Oct; 46(10):5077-83. PubMed ID: 3489521
[TBL] [Abstract][Full Text] [Related]
4. Lysis of tumor cells by human blood monocytes by a mechanism independent of activation of the oxidative burst.
Kleinerman ES; Ceccorulli LM; Bonvini E; Zicht R; Gallin JI
Cancer Res; 1985 May; 45(5):2058-64. PubMed ID: 2985242
[TBL] [Abstract][Full Text] [Related]
5. Characterization and isolation of a C-reactive protein receptor from the human monocytic cell line U-937.
Tebo JM; Mortensen RF
J Immunol; 1990 Jan; 144(1):231-8. PubMed ID: 2153164
[TBL] [Abstract][Full Text] [Related]
6. Binding of C-reactive protein to nucleated cells leads to complement activation without cytolysis.
Berman S; Gewurz H; Mold C
J Immunol; 1986 Feb; 136(4):1354-9. PubMed ID: 3944459
[TBL] [Abstract][Full Text] [Related]
7. Macrophage activation and generation of tumoricidal activity by liposome-associated human C-reactive protein.
Barna BP; Deodhar SD; Gautam S; Yen-Lieberman B; Roberts D
Cancer Res; 1984 Jan; 44(1):305-10. PubMed ID: 6690042
[TBL] [Abstract][Full Text] [Related]
8. Comparative analysis of the priming effect of human interferon-gamma, -alpha, and -beta on synergism with muramyl dipeptide analog for anti-tumor expression of human blood monocytes.
Utsugi T; Sone S
J Immunol; 1986 Feb; 136(3):1117-22. PubMed ID: 3079797
[TBL] [Abstract][Full Text] [Related]
9. Persistent activation of nuclear factor kappa-B signaling pathway in patients with unstable angina and elevated levels of C-reactive protein evidence for a direct proinflammatory effect of azide and lipopolysaccharide-free C-reactive protein on human monocytes via nuclear factor kappa-B activation.
Liuzzo G; Santamaria M; Biasucci LM; Narducci M; Colafrancesco V; Porto A; Brugaletta S; Pinnelli M; Rizzello V; Maseri A; Crea F
J Am Coll Cardiol; 2007 Jan; 49(2):185-94. PubMed ID: 17222729
[TBL] [Abstract][Full Text] [Related]
10. Modulation of human alveolar macrophage tumoricidal activity by C-reactive protein.
Barna BP; Thomassen MJ; Wiedemann HP; Ahmad M; Deodhar SD
J Biol Response Mod; 1988 Oct; 7(5):483-7. PubMed ID: 3183685
[TBL] [Abstract][Full Text] [Related]
11. C-reactive protein does not directly induce tissue factor in human monocytes.
Paffen E; Vos HL; Bertina RM
Arterioscler Thromb Vasc Biol; 2004 May; 24(5):975-81. PubMed ID: 15044210
[TBL] [Abstract][Full Text] [Related]
12. Simvastatin inhibits interleukin-6 release in human monocytes stimulated by C-reactive protein and lipopolysaccharide.
Li JJ; Chen XJ
Coron Artery Dis; 2003 Jun; 14(4):329-34. PubMed ID: 12826933
[TBL] [Abstract][Full Text] [Related]
13. Rapid killing of actinomycin D-treated tumor cells by human monocytes. II. Cytotoxicity is independent of secretion of reactive oxygen intermediates and is suppressed by protease inhibitors.
Colotta F; Bersani L; Lazzarin A; Poli G; Mantovani A
J Immunol; 1985 May; 134(5):3524-31. PubMed ID: 4038989
[TBL] [Abstract][Full Text] [Related]
14. C-reactive protein-induced colony-stimulating factors production by macrophages.
Singh PP; Singh S; Dutta GP; Singh NB
Eur Cytokine Netw; 1995; 6(1):37-43. PubMed ID: 7795173
[TBL] [Abstract][Full Text] [Related]
15. Rapid killing of actinomycin D-treated tumor cells by human mononuclear cells. I. Effectors belong to the monocyte-macrophage lineage.
Colotta F; Peri G; Villa A; Mantovani A
J Immunol; 1984 Feb; 132(2):936-44. PubMed ID: 6690624
[TBL] [Abstract][Full Text] [Related]
16. Role of interleukin 1 in promoting human monocyte-mediated tumor cytotoxicity.
Onozaki K; Matsushima K; Kleinerman ES; Saito T; Oppenheim JJ
J Immunol; 1985 Jul; 135(1):314-20. PubMed ID: 3873493
[TBL] [Abstract][Full Text] [Related]
17. Monoclonal antibody to the type II Fc receptor for human IgG blocks potentiation of monocyte and neutrophil IgG-induced respiratory burst activation by aggregated C-reactive protein.
Zeller JM; Sullivan BL
Cell Immunol; 1993 Jun; 149(1):144-54. PubMed ID: 8513509
[TBL] [Abstract][Full Text] [Related]
18. Enhancement of human monocyte tumoricidal activity by recombinant M-CSF.
Sampson-Johannes A; Carlino JA
J Immunol; 1988 Nov; 141(10):3680-6. PubMed ID: 3053901
[TBL] [Abstract][Full Text] [Related]
19. Anti-C-reactive protein inhibits cytoskeletal rearrangement without altering calcium influx in natural killer cell activation.
Khattri R; Hansen B; Nichols TC; Palmer KL; Gilman-Sachs A; Baum LL
Cell Immunol; 1994 May; 155(2):457-75. PubMed ID: 8181076
[TBL] [Abstract][Full Text] [Related]
20. Monocyte-mediated augmentation of human natural killer cell activity: conditions, monocyte and effector cell characteristics.
Bloom ET; Babbitt JT; Kawakami K
J Immunol; 1986 Jul; 137(1):172-8. PubMed ID: 3711665
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
